ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
245 | (±¹³»)SCI | Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion |
244 | (±¹³»)KCI | Colonic Perforation After Treatment With Nivolumab in Esophageal Cancer: A Case Report |
243 | (±¹¿Ü)SCIE | Genetic Polymorphisms in miR-604A>G, miR-938G>A, miR-1302-3C>T and the Risk of Idiopathic Recurrent Pregnancy Loss |
242 | (±¹³»)SCI | Clinical Impact of Natural Killer Group 2D Receptor Expression and That of Its Ligand in Ovarian Carcinomas: A Retrospective Study |
241 | (±¹¿Ü)SCIE | Mechanical properties and degradation process of biliary self-expandable biodegradable stents |
240 | (±¹¿Ü)SCIE | Synthetic lethality-mediated precision oncology via the tumor transcriptome |
239 | (±¹¿Ü)SCIE | Synergismof AZD6738, an ATR Inhibitor, in Combination with Belotecan, a Camptothecin Analogue, in Chemotherapy-Resistant Ovarian Cancer |
238 | (±¹¿Ü)SCIE | Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics |
237 | (±¹¿Ü)SCIE | IL-27 Enhances IL-15/IL-18-mediated Activation of Human Natural Killer Cells |
236 | (±¹¿Ü)SCI | Cationic nanoparticle-mediated activation of natural killer cells for effective cancer immunotherapy |
Copyright ¨Ï chamc, All rights reserved.